Department of Clinical Genetics, Shengjing Hospital of China Medical University, No. 36 San Hao Street, Shenyang, 110004, People's Republic of China.
Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 36 San Hao Street, Shenyang, 11000, People's Republic of China.
J Endocrinol Invest. 2023 Aug;46(8):1613-1622. doi: 10.1007/s40618-023-02020-8. Epub 2023 Feb 6.
46,XY disorders of sex development (DSD) is the most complicated and common type of DSD. To date, more than 30 genes have been identified associated with 46,XY DSD. However, the mutation spectrum of 46,XY DSD is incomplete owing to the high genetic and clinical heterogeneity. This study aims to provide clinical and mutational characteristics of 18 Chinese patients with 46,XY DSD.
A total of 20 unrelated individuals with 46,XY DSD were recruited. Whole-exome sequencing (WES) or custom-panel sequencing combined Sanger sequencing were performed to detect the pathogenic mutations. The pathogenicity of the variant was assessed according to the American College of Medical Genetics and Genomics (ACMG) guidance and technical standards recommended by the ACMG and the Clinical Genome Resource (ClinGen).
Six patients harbored NR5A1 mutations; two patients harbored NR0B1 mutations; six patients harbored SRD5A2 mutations; six patients harbored AR mutations. Six novel genetic variants were identified involved in three genes (NR5A1, NR0B1, and AR).
We determined the genetic etiology for all enrolled patients. Our study expanded the mutation spectrum of 46,XY DSD and provided diagnostic evidence for patients with the same mutation in the future.
46,XY 性发育障碍(DSD)是最复杂和常见的 DSD 类型。迄今为止,已有 30 多个基因与 46,XY DSD 相关。然而,由于遗传和临床高度异质性,46,XY DSD 的突变谱并不完整。本研究旨在提供 18 例中国 46,XY DSD 患者的临床和突变特征。
共招募了 20 名无关的 46,XY DSD 个体。进行全外显子组测序(WES)或定制面板测序结合 Sanger 测序,以检测致病性突变。根据美国医学遗传学与基因组学学院(ACMG)指南以及 ACMG 和临床基因组资源(ClinGen)推荐的技术标准,评估变异的致病性。
6 名患者携带 NR5A1 突变;2 名患者携带 NR0B1 突变;6 名患者携带 SRD5A2 突变;6 名患者携带 AR 突变。确定了涉及三个基因(NR5A1、NR0B1 和 AR)的 6 个新的遗传变异。
我们确定了所有入组患者的遗传病因。我们的研究扩展了 46,XY DSD 的突变谱,并为未来具有相同突变的患者提供了诊断依据。